Figure 2From: Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker Scanned image of fragments of RPPMs showing spotted triplicates of plasma and mouse IgGs probed with (+) or without (-) primary anti-clusterin antibody, and with secondary fluorescently labeled anti-IgG antibody. Pseudo-color scale, dark blue to white corresponds to increasing fluorescence.Back to article page